STOP Medicare Laboratory Rate Cuts

CMS proposed rates are below market and will cause significant negative impacts to Medicare beneficiary access to lab services.


Economic Impact Study

With an economic impact of $100 billion, clinical laboratory services promote economic growth in local communities.


ACLA to CMS: Overall Finalized Rates Still Fundamentally Flawed, Agency Must Halt Implementation

ACLA Writes CMS Administrator Verma on PAMA

Urging delay and fix to PAMA


Register Now: ACLA’s 2018 Annual Meeting

Registration for our 2018 Annual Meeting is now open!


ACLA Comments on Bucshon-DeGette Discussion Draft Impacting the Regulation of Clinical Laboratory Diagnostics

The Protecting Access to Medicare Act of 2014

Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law. 

Learn More »


Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.


View all news & updates » Recent News & Updates

View all news & updates »

Policy Issues

  • Reimbursement and Coverage

    Medicare cuts to clinical labs threaten jobs, stifle innovation, and put patient access to vital lab tests at risk.

    Continue Reading »

  • Laboratory Developed Tests

    ACLA believes now is the appropriate time to develop a logical laboratory-developed test (LDT) framework that promotes innovation and advances patient care.

    Continue Reading »

  • IOAS Exception

    Self-referral leads to over-utilization, mistreated patients, and billions of wasted Medicare dollars. It’s time to close the loophole.

    Continue Reading »

View all policy issues »